Repeated transcranial magnetic stimulation (rTMS) for idiopathic facial nerve palsy: a prospective, randomized controlled trial

Efficacy and mechanism of repetitive transcranial magnetic stimulation (rTMS) in idiopathic facial palsy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052642

Enrollment

Unknown

Registered

2021-11-02

Start date

2021-10-28

Completion date

Unknown

Last updated

2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial nerve palsy

Interventions

Experimental group:Repeated transcranial magnetic stimulation

Control group:conventional therapy

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with Bell's palsy (idiopathic facial neuritis) and facial nerve damage by electromyography; 2. The first onset and unilateral paralysis; 3. Aged 18 to 75 years; 4. Those who voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Clearly identified as a patient with central facial paralysis; 2. Facial paralysis caused by Lyme disease, encephalitis, tumor or trauma and other reasons; 3. Confused and unable to cooperate with the treatment of patients; 4. Contraindications for transcranial magnetic stimulation such as pregnancy or intracranial metal foreign body, history of epilepsy, implanted pacemaker, etc.; 5. Patients with poor treatment compliance.

Design outcomes

Primary

Measure	Time frame
House-Brackmann;Portmann Easy Scoring;Toronto Facial Nerve Rating Scale;	—

Countries

China

Contacts

Public ContactLiu Huiyu

Yuebei People's Hospital

liuhuiyudoctor@sohu.com+86 13922599818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026